General
Preferred name
METHYLTHIOURACIL
Synonyms
6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one ()
6-Methyl-2-thiouracil ()
NSC-193526, NSC-9378,MTU ()
MTU ()
NSC-193526 ()
Methylthiouracile ()
Thimecil ()
Metiltiouracilo ()
P&D ID
PD001856
CAS
56-04-2
Tags
available
drug
Drug Status
approved
investigational
experimental
Max Phase
2.0
Drug indication
Abnormality of the thyroid gland
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Methylthiouracil is an antithyroid agent. Methylthiouracil suppresses the production TNF-¦Á and IL-6, and the activation of NF-¦ÊB and ERK1/2.
PRICE 29
DESCRIPTION Methylthiouracil (NSC-193526) is a thiourea antithyroid agent that inhibits the synthesis of thyroid hormone, and it is used to treat hyperthyroidism.
DESCRIPTION Methylthiouracil is an antithyroid preparation.The drug acts to decrease the formation of stored thyroid hormone, as thyroglobulin in the thyroid gland. (BOC Sciences Bioactive Compounds)
DESCRIPTION PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) (TargetMol Bioactive Compound Library)
Compound Sets
13
BOC Sciences Bioactive Compounds
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
NPC Screening Collection
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
46
Properties
(calculated by RDKit )
Molecular Weight
142.02
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
1
Aromatic Ring Count
1
cLogP
0.74
TPSA
48.65
Fraction CSP3
0.2
Chiral centers
0.0
Largest ring
6.0
QED
0.52
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
NF-¦ÊB
ERK,Interleukins,NF-¦ÊB,TNF-alpha
ERK
Interleukin Related
TNF Receptor
Pathway
NF-??
Apoptosis
Immunology/Inflammation
MAPK/ERK Pathway
NF-κB
Stem Cell/Wnt
Indication
hyperthyroidism
Source data